 | • レポートコード：QYR2104Z5833 • 出版社/出版日：QYResearch / 2021年4月15日 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、尿路感染症（UTI）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（上部尿路感染症、下部尿路感染症）、用途別市場規模（病院、診療所、自己管理、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・尿路感染症（UTI）の市場動向 ・企業の競争状況、市場シェア ・尿路感染症（UTI）の種類別市場規模（上部尿路感染症、下部尿路感染症） ・尿路感染症（UTI）の用途別市場規模（病院、診療所、自己管理、その他） ・尿路感染症（UTI）の北米市場規模2016-2027（アメリカ、カナダ） ・尿路感染症（UTI）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・尿路感染症（UTI）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・尿路感染症（UTI）の中南米市場規模2016-2027（メキシコ、ブラジル） ・尿路感染症（UTI）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis AG、GlaxoSmithKline、Dr. Reddy’s Laboratories Ltd.,、Pfizer、Roche、AstraZeneca,、Cipla、Johnson & Johnson、Bayer AG、Teva Pharmaceutical Industries、Boehringer Ingelheim、Sanofi、Lily、Abbott、JinShuiBao、Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)、Sinopharm、Borui Medicine、Zhejiang Xianju Pharmaceutical、Sichuan Guorui Pharmaceutical、Hengrui Pharmaceutical） ・結論 |
Urinary tract infection (UTI), is an infectious disease caused by the growth and proliferation of pathogens in the urinary tract.Pathogens may include bacteria, mycoplasma, chlamydia, viruses, etc.Urinary tract infection is the second most common infectious disease after respiratory tract infection.Shock deaths from urinary tract infections were the third leading cause of death.
Market Analysis and Insights: Global Urinary Tract Infection (UTI) Market
The global Urinary Tract Infection (UTI) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urinary Tract Infection (UTI) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urinary Tract Infection (UTI) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urinary Tract Infection (UTI) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urinary Tract Infection (UTI) market.
Global Urinary Tract Infection (UTI) Scope and Market Size
Urinary Tract Infection (UTI) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urinary Tract Infection (UTI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Site of Infection
Upper Urinary Tract Infection
Lower Urinary Tract Infection
By Clinical Symptoms
Symptomatic Urinary Tract Infection
Asymptomatic Urinary Tract Infection
By Presence of Urinary Tract Abnormalities
Simple/uncomplicated Urinary Tract Infection
Complex Urinary Tract Infection
Segment by Application
Hospitals
Clinic
Self-administered
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novartis AG
GlaxoSmithKline
Dr. Reddy’s Laboratories Ltd.,
Pfizer
Roche
AstraZeneca,
Cipla
Johnson & Johnson
Bayer AG
Teva Pharmaceutical Industries
Boehringer Ingelheim
Sanofi
Lily
Abbott
JinShuiBao
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
Borui Medicine
Zhejiang Xianju Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Upper Urinary Tract Infection
1.2.3 Lower Urinary Tract Infection
1.3 Market by Application
1.3.1 Global Urinary Tract Infection (UTI) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Self-administered
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Urinary Tract Infection (UTI) Market Perspective (2016-2027)
2.2 Urinary Tract Infection (UTI) Growth Trends by Regions
2.2.1 Urinary Tract Infection (UTI) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Urinary Tract Infection (UTI) Historic Market Share by Regions (2016-2021)
2.2.3 Urinary Tract Infection (UTI) Forecasted Market Size by Regions (2022-2027)
2.3 Urinary Tract Infection (UTI) Industry Dynamic
2.3.1 Urinary Tract Infection (UTI) Market Trends
2.3.2 Urinary Tract Infection (UTI) Market Drivers
2.3.3 Urinary Tract Infection (UTI) Market Challenges
2.3.4 Urinary Tract Infection (UTI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urinary Tract Infection (UTI) Players by Revenue
3.1.1 Global Top Urinary Tract Infection (UTI) Players by Revenue (2016-2021)
3.1.2 Global Urinary Tract Infection (UTI) Revenue Market Share by Players (2016-2021)
3.2 Global Urinary Tract Infection (UTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Urinary Tract Infection (UTI) Revenue
3.4 Global Urinary Tract Infection (UTI) Market Concentration Ratio
3.4.1 Global Urinary Tract Infection (UTI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection (UTI) Revenue in 2020
3.5 Urinary Tract Infection (UTI) Key Players Head office and Area Served
3.6 Key Players Urinary Tract Infection (UTI) Product Solution and Service
3.7 Date of Enter into Urinary Tract Infection (UTI) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urinary Tract Infection (UTI) Breakdown Data by Type
4.1 Global Urinary Tract Infection (UTI) Historic Market Size by Type (2016-2021)
4.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2022-2027)
5 Urinary Tract Infection (UTI) Breakdown Data by Application
5.1 Global Urinary Tract Infection (UTI) Historic Market Size by Application (2016-2021)
5.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Urinary Tract Infection (UTI) Market Size (2016-2027)
6.2 North America Urinary Tract Infection (UTI) Market Size by Type
6.2.1 North America Urinary Tract Infection (UTI) Market Size by Type (2016-2021)
6.2.2 North America Urinary Tract Infection (UTI) Market Size by Type (2022-2027)
6.2.3 North America Urinary Tract Infection (UTI) Market Size by Type (2016-2027)
6.3 North America Urinary Tract Infection (UTI) Market Size by Application
6.3.1 North America Urinary Tract Infection (UTI) Market Size by Application (2016-2021)
6.3.2 North America Urinary Tract Infection (UTI) Market Size by Application (2022-2027)
6.3.3 North America Urinary Tract Infection (UTI) Market Size by Application (2016-2027)
6.4 North America Urinary Tract Infection (UTI) Market Size by Country
6.4.1 North America Urinary Tract Infection (UTI) Market Size by Country (2016-2021)
6.4.2 North America Urinary Tract Infection (UTI) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Urinary Tract Infection (UTI) Market Size (2016-2027)
7.2 Europe Urinary Tract Infection (UTI) Market Size by Type
7.2.1 Europe Urinary Tract Infection (UTI) Market Size by Type (2016-2021)
7.2.2 Europe Urinary Tract Infection (UTI) Market Size by Type (2022-2027)
7.2.3 Europe Urinary Tract Infection (UTI) Market Size by Type (2016-2027)
7.3 Europe Urinary Tract Infection (UTI) Market Size by Application
7.3.1 Europe Urinary Tract Infection (UTI) Market Size by Application (2016-2021)
7.3.2 Europe Urinary Tract Infection (UTI) Market Size by Application (2022-2027)
7.3.3 Europe Urinary Tract Infection (UTI) Market Size by Application (2016-2027)
7.4 Europe Urinary Tract Infection (UTI) Market Size by Country
7.4.1 Europe Urinary Tract Infection (UTI) Market Size by Country (2016-2021)
7.4.2 Europe Urinary Tract Infection (UTI) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size (2016-2027)
8.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type
8.2.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2016-2027)
8.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application
8.3.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2016-2027)
8.4 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region
8.4.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Urinary Tract Infection (UTI) Market Size (2016-2027)
9.2 Latin America Urinary Tract Infection (UTI) Market Size by Type
9.2.1 Latin America Urinary Tract Infection (UTI) Market Size by Type (2016-2021)
9.2.2 Latin America Urinary Tract Infection (UTI) Market Size by Type (2022-2027)
9.2.3 Latin America Urinary Tract Infection (UTI) Market Size by Type (2016-2027)
9.3 Latin America Urinary Tract Infection (UTI) Market Size by Application
9.3.1 Latin America Urinary Tract Infection (UTI) Market Size by Application (2016-2021)
9.3.2 Latin America Urinary Tract Infection (UTI) Market Size by Application (2022-2027)
9.3.3 Latin America Urinary Tract Infection (UTI) Market Size by Application (2016-2027)
9.4 Latin America Urinary Tract Infection (UTI) Market Size by Country
9.4.1 Latin America Urinary Tract Infection (UTI) Market Size by Country (2016-2021)
9.4.2 Latin America Urinary Tract Infection (UTI) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size (2016-2027)
10.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type
10.2.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2016-2027)
10.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application
10.3.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2016-2027)
10.4 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country
10.4.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Urinary Tract Infection (UTI) Introduction
11.1.4 Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Urinary Tract Infection (UTI) Introduction
11.2.4 GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Dr. Reddy’s Laboratories Ltd.,
11.3.1 Dr. Reddy’s Laboratories Ltd., Company Details
11.3.2 Dr. Reddy’s Laboratories Ltd., Business Overview
11.3.3 Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Introduction
11.3.4 Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.3.5 Dr. Reddy’s Laboratories Ltd., Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Urinary Tract Infection (UTI) Introduction
11.4.4 Pfizer Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Urinary Tract Infection (UTI) Introduction
11.5.4 Roche Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.5.5 Roche Recent Development
11.6 AstraZeneca,
11.6.1 AstraZeneca, Company Details
11.6.2 AstraZeneca, Business Overview
11.6.3 AstraZeneca, Urinary Tract Infection (UTI) Introduction
11.6.4 AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.6.5 AstraZeneca, Recent Development
11.7 Cipla
11.7.1 Cipla Company Details
11.7.2 Cipla Business Overview
11.7.3 Cipla Urinary Tract Infection (UTI) Introduction
11.7.4 Cipla Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.7.5 Cipla Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Urinary Tract Infection (UTI) Introduction
11.8.4 Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Urinary Tract Infection (UTI) Introduction
11.9.4 Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.9.5 Bayer AG Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Details
11.10.2 Teva Pharmaceutical Industries Business Overview
11.10.3 Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Introduction
11.10.4 Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Urinary Tract Infection (UTI) Introduction
11.11.4 Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Urinary Tract Infection (UTI) Introduction
11.12.4 Sanofi Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Lily
11.13.1 Lily Company Details
11.13.2 Lily Business Overview
11.13.3 Lily Urinary Tract Infection (UTI) Introduction
11.13.4 Lily Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.13.5 Lily Recent Development
11.14 Abbott
11.14.1 Abbott Company Details
11.14.2 Abbott Business Overview
11.14.3 Abbott Urinary Tract Infection (UTI) Introduction
11.14.4 Abbott Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.14.5 Abbott Recent Development
11.15 JinShuiBao
11.15.1 JinShuiBao Company Details
11.15.2 JinShuiBao Business Overview
11.15.3 JinShuiBao Urinary Tract Infection (UTI) Introduction
11.15.4 JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.15.5 JinShuiBao Recent Development
11.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
11.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Introduction
11.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.17 Sinopharm
11.17.1 Sinopharm Company Details
11.17.2 Sinopharm Business Overview
11.17.3 Sinopharm Urinary Tract Infection (UTI) Introduction
11.17.4 Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.17.5 Sinopharm Recent Development
11.18 Borui Medicine
11.18.1 Borui Medicine Company Details
11.18.2 Borui Medicine Business Overview
11.18.3 Borui Medicine Urinary Tract Infection (UTI) Introduction
11.18.4 Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.18.5 Borui Medicine Recent Development
11.18 Zhejiang Xianju Pharmaceutical
.1 Zhejiang Xianju Pharmaceutical Company Details
.2 Zhejiang Xianju Pharmaceutical Business Overview
.3 Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Introduction
.4 Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
.5 Zhejiang Xianju Pharmaceutical Recent Development
11.20 Sichuan Guorui Pharmaceutical
11.20.1 Sichuan Guorui Pharmaceutical Company Details
11.20.2 Sichuan Guorui Pharmaceutical Business Overview
11.20.3 Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Introduction
11.20.4 Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.20.5 Sichuan Guorui Pharmaceutical Recent Development
11.21 Hengrui Pharmaceutical
11.21.1 Hengrui Pharmaceutical Company Details
11.21.2 Hengrui Pharmaceutical Business Overview
11.21.3 Hengrui Pharmaceutical Urinary Tract Infection (UTI) Introduction
11.21.4 Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021)
11.21.5 Hengrui Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Upper Urinary Tract Infection
Table 3. Key Players of Lower Urinary Tract Infection
Table 4. Global Urinary Tract Infection (UTI) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Urinary Tract Infection (UTI) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Urinary Tract Infection (UTI) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Urinary Tract Infection (UTI) Market Share by Regions (2016-2021)
Table 8. Global Urinary Tract Infection (UTI) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Urinary Tract Infection (UTI) Market Share by Regions (2022-2027)
Table 10. Urinary Tract Infection (UTI) Market Trends
Table 11. Urinary Tract Infection (UTI) Market Drivers
Table 12. Urinary Tract Infection (UTI) Market Challenges
Table 13. Urinary Tract Infection (UTI) Market Restraints
Table 14. Global Urinary Tract Infection (UTI) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Urinary Tract Infection (UTI) Market Share by Players (2016-2021)
Table 16. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection (UTI) as of 2020)
Table 17. Ranking of Global Top Urinary Tract Infection (UTI) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Urinary Tract Infection (UTI) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Urinary Tract Infection (UTI) Product Solution and Service
Table 21. Date of Enter into Urinary Tract Infection (UTI) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2016-2021)
Table 25. Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Urinary Tract Infection (UTI) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2016-2021)
Table 29. Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Urinary Tract Infection (UTI) Product
Table 64. Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Urinary Tract Infection (UTI) Product
Table 69. GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Dr. Reddy’s Laboratories Ltd., Company Details
Table 72. Dr. Reddy’s Laboratories Ltd., Business Overview
Table 73. Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Product
Table 74. Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 75. Dr. Reddy’s Laboratories Ltd., Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Urinary Tract Infection (UTI) Product
Table 79. Pfizer Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Urinary Tract Infection (UTI) Product
Table 84. Roche Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. AstraZeneca, Company Details
Table 87. AstraZeneca, Business Overview
Table 88. AstraZeneca, Urinary Tract Infection (UTI) Product
Table 89. AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca, Recent Development
Table 91. Cipla Company Details
Table 92. Cipla Business Overview
Table 93. Cipla Urinary Tract Infection (UTI) Product
Table 94. Cipla Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 95. Cipla Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 99. Johnson & Johnson Recent Development
Table 100. Bayer AG Company Details
Table 101. Bayer AG Business Overview
Table 102. Bayer AG Urinary Tract Infection (UTI) Product
Table 103. Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 104. Bayer AG Recent Development
Table 105. Teva Pharmaceutical Industries Company Details
Table 106. Teva Pharmaceutical Industries Business Overview
Table 107. Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Product
Table 108. Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 109. Teva Pharmaceutical Industries Recent Development
Table 110. Boehringer Ingelheim Company Details
Table 111. Boehringer Ingelheim Business Overview
Table 112. Boehringer Ingelheim Urinary Tract Infection (UTI) Product
Table 113. Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 114. Boehringer Ingelheim Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Business Overview
Table 117. Sanofi Urinary Tract Infection (UTI) Product
Table 118. Sanofi Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 119. Sanofi Recent Development
Table 120. Lily Company Details
Table 121. Lily Business Overview
Table 122. Lily Urinary Tract Infection (UTI) Product
Table 123. Lily Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 124. Lily Recent Development
Table 125. Abbott Company Details
Table 126. Abbott Business Overview
Table 127. Abbott Urinary Tract Infection (UTI) Product
Table 128. Abbott Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 129. Abbott Recent Development
Table 130. JinShuiBao Company Details
Table 131. JinShuiBao Business Overview
Table 132. JinShuiBao Urinary Tract Infection (UTI) Product
Table 133. JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 134. JinShuiBao Recent Development
Table 135. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
Table 136. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 137. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Product
Table 138. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 139. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 140. Sinopharm Company Details
Table 141. Sinopharm Business Overview
Table 142. Sinopharm Urinary Tract Infection (UTI) Product
Table 143. Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 144. Sinopharm Recent Development
Table 145. Borui Medicine Company Details
Table 146. Borui Medicine Business Overview
Table 147. Borui Medicine Urinary Tract Infection (UTI) Product
Table 148. Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 149. Borui Medicine Recent Development
Table 150. Zhejiang Xianju Pharmaceutical Company Details
Table 151. Zhejiang Xianju Pharmaceutical Business Overview
Table 152. Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Product
Table 153. Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 154. Zhejiang Xianju Pharmaceutical Recent Development
Table 155. Sichuan Guorui Pharmaceutical Company Details
Table 156. Sichuan Guorui Pharmaceutical Business Overview
Table 157. Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Product
Table 158. Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 159. Sichuan Guorui Pharmaceutical Recent Development
Table 160. Hengrui Pharmaceutical Company Details
Table 161. Hengrui Pharmaceutical Business Overview
Table 162. Hengrui Pharmaceutical Urinary Tract Infection (UTI) Product
Table 163. Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million)
Table 164. Hengrui Pharmaceutical Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urinary Tract Infection (UTI) Market Share by Type: 2020 VS 2027
Figure 2. Upper Urinary Tract Infection Features
Figure 3. Lower Urinary Tract Infection Features
Figure 4. Global Urinary Tract Infection (UTI) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Self-administered Case Studies
Figure 8. Others Case Studies
Figure 9. Urinary Tract Infection (UTI) Report Years Considered
Figure 10. Global Urinary Tract Infection (UTI) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Urinary Tract Infection (UTI) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Urinary Tract Infection (UTI) Market Share by Regions: 2020 VS 2027
Figure 13. Global Urinary Tract Infection (UTI) Market Share by Regions (2022-2027)
Figure 14. Global Urinary Tract Infection (UTI) Market Share by Players in 2020
Figure 15. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection (UTI) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Urinary Tract Infection (UTI) Revenue in 2020
Figure 17. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2016-2021)
Figure 18. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2022-2027)
Figure 19. North America Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Urinary Tract Infection (UTI) Market Share by Type (2016-2027)
Figure 21. North America Urinary Tract Infection (UTI) Market Share by Application (2016-2027)
Figure 22. North America Urinary Tract Infection (UTI) Market Share by Country (2016-2027)
Figure 23. United States Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Urinary Tract Infection (UTI) Market Share by Type (2016-2027)
Figure 27. Europe Urinary Tract Infection (UTI) Market Share by Application (2016-2027)
Figure 28. Europe Urinary Tract Infection (UTI) Market Share by Country (2016-2027)
Figure 29. Germany Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Region (2016-2027)
Figure 39. China Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Urinary Tract Infection (UTI) Market Share by Type (2016-2027)
Figure 47. Latin America Urinary Tract Infection (UTI) Market Share by Application (2016-2027)
Figure 48. Latin America Urinary Tract Infection (UTI) Market Share by Country (2016-2027)
Figure 49. Mexico Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Country (2016-2027)
Figure 55. Turkey Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 60. Dr. Reddy’s Laboratories Ltd., Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 63. AstraZeneca, Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 64. Cipla Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 70. Lily Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 71. Abbott Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 72. JinShuiBao Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 73. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 74. Sinopharm Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 75. Borui Medicine Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 76. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 77. Sichuan Guorui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 78. Hengrui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed